OGT-IN-2

CAS No. 442665-87-4

OGT-IN-2 ( —— )

Catalog No. M28850 CAS No. 442665-87-4

OGT-IN-2 is a potent O-GlcNAc transferase (OGT) inhibitor. OGT-IN-2 inhibits sOGT and ncOGT with IC50 values of 30 μM and 53 μM, respectively. OGT-IN-2 can be used for the research of articular diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 87 Get Quote
5MG 151 Get Quote
10MG 224 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    OGT-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    OGT-IN-2 is a potent O-GlcNAc transferase (OGT) inhibitor. OGT-IN-2 inhibits sOGT and ncOGT with IC50 values of 30 μM and 53 μM, respectively. OGT-IN-2 can be used for the research of articular diseases.
  • Description
    OGT-IN-2 is a potent O-GlcNAc transferase (OGT) inhibitor. OGT-IN-2 inhibits sOGT and ncOGT with IC50 values of 30 μM and 53 μM, respectively. OGT-IN-2 can be used for the research of articular diseases.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    5-HT5A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    442665-87-4
  • Formula Weight
    447.0
  • Molecular Formula
    C23H27ClN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(C(CC(N1CCC2(CC(C3)C4)CC4CC3C2)=O)SC1=Nc(cc1)ccc1Cl)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Aparicio-Nava L, Márquez-García LA, Meneses A. Effects of 5-HT5A receptor blockade on amnesia or forgetting. Behav Brain Res. 2019 Jan 14;357-358:98-103.
molnova catalog
related products
  • beta-Hydroxyacteosid...

    beta-Hydroxyacteoside.

  • TOPS

    TOPS is a Trinder's reagent and is widely used in diagnostic tests and biochemical tests.

  • Ensartinib hydrochlo...

    Ensartinib dihydrochloride is a potent new-generation ALK inhibitor with high activity against CNS metastases and a broad range of known crizotinib-resistant ALK mutations.